Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory (Oncotarget (2017) 8 (41806-41814) DOI: 10.18632/oncotarget.16018;A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

Oncotarget

Volumn 8, Issue 26, 2017, Pages 41806-41814

  Arango, Natalia Paez ^a   Brusco, Lauren ^a   Shaw, Kenna R Mills ^a   Chen, Ken ^a   Eterovic, Agda Karina ^a   Holla, Vijaykumar ^a   Johnson, Amber ^a   Litzenburger, Beate ^a   Khotskaya, Yekaterina B ^a   Sanchez, Nora ^a   Bailey, Ann ^a   Zheng, Xiaofeng ^a   Horombe, Chacha ^a   Kopetz, Scott ^a   Farhangfar, Carol J ^b   Routbort, Mark ^a   Broaddus, Russell ^a   Bernstam, Elmer V ^c   Mendelsohn, John ^a   Mills, Gordon B ^a   Meric Bernstam, Funda ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LEVINE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

CLIA; Clinical trial; Genomics; Precision medicine; Somatic mutation

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN CANCER; BREAST CANCER; CHILD; COPY NUMBER VARIATION; DIGESTIVE SYSTEM CANCER; FEASIBILITY STUDY; FEMALE; FEMALE GENITAL TRACT CANCER; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; MUTATIONAL ANALYSIS; PHARMACOGENOMICS; PROSPECTIVE STUDY; SARCOMA; SKIN CANCER; SOMATIC MUTATION; TURNAROUND TIME; ALGORITHM; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; GENETIC VARIATION; GENETICS; GENOMICS; HUMAN GENOME; LABORATORY; METHODOLOGY; MIDDLE AGED; MUTATION; NEOPLASM; PERSONALIZED MEDICINE; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; RESEARCH; VERY ELDERLY; WORKFLOW; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEASIBILITY STUDIES; FEMALE; GENETIC TESTING; GENETIC VARIATION; GENOME, HUMAN; GENOMICS; HUMANS; LABORATORIES; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; PRECISION MEDICINE; REPRODUCIBILITY OF RESULTS; RESEARCH; RESEARCH DESIGN; WORKFLOW; YOUNG ADULT;

EID: 85021296288     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.27176     Document Type: Erratum

References (13)

1. Hansen AR, Bedard PL. Clinical application of highthroughput genomic technologies for treatment selection in breast cancer. Breast Cancer Res. 2013; 15:R97
2. Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, Lipkin SM, Syngal S, Wollins DS, Lindor NM. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. J Clin Oncol. 2015; 33:3660-67
3. Meric-Bernstam F, Brusco L, Daniels M, Wathoo C, Bailey AM, Strong L, Shaw K, Lu K, Qi Y, Zhao H, Lara-Guerra H, Litton J, Arun B, et al. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol. 2016; 27:795-800
4. Chen K, Meric-Bernstam F, Zhao H, Zhang Q, Ezzeddine N, Tang LY, Qi Y, Mao Y, Chen T, Chong Z, Zhou W, Zheng X, Johnson A, et al. Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem. 2015; 61:544-53
5. Meric-Bernstam F, Brusco L, Shaw K, Horombe C, Kopetz S, Davies MA, Routbort M, Piha-Paul SA, Janku F, Ueno N, Hong D, De Groot J, Ravi V, et al, and Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol. 2015; 33:2753-62
6. Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, Jane-Valbuena J, Friedrich DC, Kryukov G, Carter SL, McKenna A, Sivachenko A, Rosenberg M, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014; 20:682-88
7. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, and ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405-24
8. Gray SW, Park ER, Najita J, Martins Y, Traeger L, Bair E, Gagne J, Garber J, Jänne PA, Lindeman N, Lowenstein C, Oliver N, Sholl L, et al. Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genet Med. 2016; 18:1011-19
9. Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spiegel D, Sweeney C, Burris H, Bose R, Guo S, Bernaards C, Beattie M, Stein A, Brammer M, Kurzrock R. Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study. in ASCO Annual Meeting. 2016 Chicago, Il
10. Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus R, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, et al. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. Am J Clin Pathol. 2015; 144:713-21
11. Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, Routbort M, Patel KP, Zeng J, Kopetz S, Davies MA, Piha-Paul SA, Hong DS, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015; 107:107
12. Johnson A, Zeng J, Bailey AM, Holla V, Litzenburger B, Lara-Guerra H, Mills GB, Mendelsohn J, Shaw KR, Meric-Bernstam F. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform. Drug Discov Today. 2015; 20:1433-38
13. Gonzalez-Angulo AM, Ferrer-Lozano J, Stemke-Hale K, Sahin A, Liu S, Barrera JA, Burgues O, Lluch AM, Chen H, Hortobagyi GN, Mills GB, Meric-Bernstam F. PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer. Mol Cancer Ther. 2011; 10:1093-101